Evidence map›Paper›PMID 32213550›Full record

ArticleBMJ open quality2020

Testicular cancer: improving outcomes with national quality performance indicators.

Mark A Baxter, Graham MacDonald, Jahangeer Malik, Alistair Law, Åsa Dahle-Smith, Walter Mmeka, Roland Donat, Cj Shukla, John Connor, Colin Houston and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open quality, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mark A BaxterUniversity of Dundee, Dundee, UK markbaxter3@nhs.net.ORCID 0000-0002-5773-8650
Graham MacDonaldDepartment of Oncology, Aberdeen Royal Infirmary, Aberdeen, UK.
Jahangeer MalikDepartment of Oncology, Western General Hospital, Edinburgh, UK.
Alistair LawDepartment of Oncology, Western General Hospital, Edinburgh, UK.
Åsa Dahle-SmithDepartment of Oncology, Ninewells Hospital, Dundee, UK.
Walter MmekaDepartment of Oncology, Raigmore Hospital, Inverness, UK.
Roland DonatDepartment of Urology, Western General Hospital, Edinburgh, UK.
Cj ShuklaDepartment of Urology, Western General Hospital, Edinburgh, UK.
John ConnorNHS Scotland National Services Division, Edinburgh, UK.
Colin HoustonNHS Scotland National Services Division, Edinburgh, UK.
Ashita WaterstonBeatson West of Scotland Cancer Centre, Glasgow, UK.
Jeff WhiteBeatson West of Scotland Cancer Centre, Glasgow, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testicular cancer is the most common malignancy in young adult men. The prognosis is excellent in limited disease and cure is possible even in advanced disease. Quality performance indicators (QPI) are used in many developed countries as a measure of healthcare performance. We report and discuss the development of a national set of QPIs in Scotland for testicular cancer as a method of gathering demographic data and driving improvement in nationwide testicular cancer outcomes.

Indexed as

Quality ImprovementHumansMaleOutcome Assessment, Health CareQuality Indicators, Health CareScotlandState MedicineTesticular Neoplasmsclinical practice guidelinescontinuous quality improvementhealthcare quality improvementperformance measuresquality improvement methodologies

Identifiers

PMID32213550
PMCPMC7206916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.